Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-17

FDA Approved: MESNA — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for MESNA submitted by Hikma Pharmaceuticals USA Inc., likely expanding or updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MESNA (MESNA)

Snippet

SUPPL AP for MESNA (MESNA)